These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6372403)

  • 21. Comparison of the subacute effects of a new glucocorticoid, deflazacort, and prednisone on the hypothalamic-pituitary-adrenal axis of normal subjects.
    Wajchenberg BL; Cesar FP; Luthold WW; Okada H; Borghi VC
    Braz J Med Biol Res; 1986; 19(1):39-47. PubMed ID: 3542091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of prednisone on insulin secretion in man: model for duplication of blood glucose concentration.
    Kalhan SC; Adam PA
    J Clin Endocrinol Metab; 1975 Sep; 41(3):600-10. PubMed ID: 1159064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variable effects of statins on glucose homeostasis parameters and their diabetogenic role.
    Kostapanos MS; Agouridis AP; Elisaf MS
    Diabetologia; 2015 Aug; 58(8):1960-1. PubMed ID: 26026652
    [No Abstract]   [Full Text] [Related]  

  • 24. Deflazacort. A review of its pharmacological properties and therapeutic efficacy.
    Markham A; Bryson HM
    Drugs; 1995 Aug; 50(2):317-33. PubMed ID: 8521761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation on the diabetogenic action of prolactin].
    Zhang ZB
    Zhonghua Nei Ke Za Zhi; 1983 Oct; 22(10):615-7. PubMed ID: 6370628
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin kinetics in juvenile canine diabetics after glucose loading.
    Atkins CE; Chin HP
    Am J Vet Res; 1983 Apr; 44(4):596-600. PubMed ID: 6346965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of blood glucose in normal and in diabetic subjects. Studies by compartmental analysis and digital computer technics.
    Ceresa F; Ghemi F; Martini PF; Martino P; Segre G; Vitelli A
    Diabetes; 1968 Sep; 17(9):570-8. PubMed ID: 5675317
    [No Abstract]   [Full Text] [Related]  

  • 28. Insulin-like and diabetogenic effects of growth hormone in healthy subjects, diabetics, and low insulin responders.
    Adamson U; Efendic S
    J Clin Endocrinol Metab; 1979 Sep; 49(3):456-61. PubMed ID: 468979
    [No Abstract]   [Full Text] [Related]  

  • 29. The dynamic insulin sensitivity and secretion test--a novel measure of insulin sensitivity.
    McAuley KA; Berkeley JE; Docherty PD; Lotz TF; Te Morenga LA; Shaw GM; Williams SM; Chase JG; Mann JI
    Metabolism; 2011 Dec; 60(12):1748-56. PubMed ID: 21704347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin secretion and sensitivity in children on cyclic total parenteral nutrition.
    Lienhardt A; Rakotoambinina B; Colomb V; Souissi S; Sadoun E; Goulet O; Robert JJ; Ricour C
    JPEN J Parenter Enteral Nutr; 1998; 22(6):382-6. PubMed ID: 9829612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deflazacort and skeletal, phosphate and glucose metabolism in monkeys.
    Beneton M; Guilland-Cumming DF; Harvey L; Imbimbo B; Russell RG; Kanis JA
    Adv Exp Med Biol; 1984; 171():101-10. PubMed ID: 6720455
    [No Abstract]   [Full Text] [Related]  

  • 32. Possible novel index determined by the glucose clamp test for selection of a suitable therapy for each type 2 diabetic patient.
    Gorogawa S; Kaneto H; Matsuhisa M; Ohtoshi K; Kawamori D; Hazama Y; Yoshiuchi K; Yamasaki Y
    Diabetes Res Clin Pract; 2005 Jul; 69(1):1-4. PubMed ID: 15955381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carbohydrate tolerance, insulin secretion and insulin sensitivity in acute pancreatitis].
    Adlung J; Koch C; Ritter U
    Z Gastroenterol; 1974 Mar; 12(2):81-6. PubMed ID: 4825093
    [No Abstract]   [Full Text] [Related]  

  • 34. Glucose intolerance in patients with thalassemia major: insulin resistance and hyperproinsulinemia.
    Cario H; Holl RW; Kohne E
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():953-5. PubMed ID: 10091170
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical equivalence of a new glucocorticoid, deflazacort and prednisone in rheumatoid arthritis and S.L.E. patients.
    Imbimbo B; Tuzi T; Porzio F; Schiavetti L
    Adv Exp Med Biol; 1984; 171():241-56. PubMed ID: 6372394
    [No Abstract]   [Full Text] [Related]  

  • 36. Prednisone increases the number of insulin receptors in erythrocytes from children.
    Canivet B; Poustis-Delpont C; Mariani R; Freychet P
    Pediatr Res; 1983 Aug; 17(8):672-5. PubMed ID: 6351007
    [No Abstract]   [Full Text] [Related]  

  • 37. Prednisone versus deflazacort in the treatment of autoimmune thrombocytopenic purpura: evaluation of clinical response and immunological modifications.
    Ferrari A; Pasqualetti D; Del Bianco P; Gandolfo GM; Chistolini A; Mazzucconi MG
    Haematologica; 1991; 76(4):342-5. PubMed ID: 1794742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-administration of deflazacort and doxycycline: a potential pharmacotherapy for Duchenne muscular dystrophy.
    Pereira JA; Marques MJ; Santo Neto H
    Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):788-94. PubMed ID: 25959722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of FK 506 on glucose metabolism and insulin secretion in normal rats.
    Tze WJ; Tai J; Murase N; Tzakis A; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3158-60. PubMed ID: 1721391
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans.
    Luzi L; DeFronzo RA
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E241-6. PubMed ID: 2669517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.